Debras B, Guillonneau B, Bougaran J, Chambon E, Vallancien G
Department of Urology, Institut Montsouris, Université Pierre et Marie Curie, Paris, France.
Eur Urol. 1998;33(3):271-7. doi: 10.1159/000019579.
The prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen was evaluated according to the proximal or distal site of this invasion.
52 consecutive patients undergoing radical prostatectomy for stage pT3b N0 M0 prostatic cancer were classified into two groups: group A (18 patients): patients with invasion limited to the proximal part of the seminal vesicles (stage T3b limited); group B (34 patients): patients with invasion extending to the free part of the seminal vesicles (stage T3b extensive). The PSA progression-free curves were compared between the two groups. A multivariable regression model was performed to determine independent prognostic factors.
Overall, the 5-year PSA progression free rate of the 52 patients was 14.4%. The 5-year PSA progression-free rate of the patients in group A was 45.4 vs. 4.2% at 4 years in group B (p = 0.0004). The stage of seminal vesicle invasion and the Gleason score were the only independent predictive factors of PSA progression (p = 0.02 and p = 0.04, respectively).
The prognostic significance of seminal vesicle invasion is not constant and depends on the site of invasion. Preoperative seminal vesicles biopsies can select patients with invasion extending to the free part of seminal vesicles and who have a poor prognosis in terms of PSA progression after radical prostatectomy.
根据精囊侵犯的近端或远端部位,评估根治性前列腺切除标本中精囊侵犯的预后意义。
52例连续接受根治性前列腺切除术治疗pT3b N0 M0期前列腺癌的患者被分为两组:A组(18例患者):侵犯局限于精囊近端部分的患者(T3b局限期);B组(34例患者):侵犯延伸至精囊游离部分的患者(T3b广泛期)。比较两组间的无前列腺特异性抗原(PSA)进展曲线。进行多变量回归模型以确定独立的预后因素。
总体而言,52例患者的5年无PSA进展率为14.4%。A组患者的5年无PSA进展率为45.4%,而B组在4年时为4.2%(p = 0.0004)。精囊侵犯分期和Gleason评分是PSA进展的仅有的独立预测因素(分别为p = 0.02和p = 0.04)。
精囊侵犯的预后意义并非恒定不变,而是取决于侵犯部位。术前精囊活检可筛选出侵犯延伸至精囊游离部分且根治性前列腺切除术后在PSA进展方面预后较差的患者。